109 related articles for article (PubMed ID: 31950840)
1. STAT3 expression is correlated with pathological stage in luminal subtypes of breast carcinoma.
Eroglu M; Kokenek-Unal TD; Akin-Bali DF; Kirimlioglu SH
Bratisl Lek Listy; 2020; 121(1):51-61. PubMed ID: 31950840
[TBL] [Abstract][Full Text] [Related]
2. EGFR dependent expression of STAT3 (but not STAT1) in breast cancer.
Berclaz G; Altermatt HJ; Rohrbach V; Siragusa A; Dreher E; Smith PD
Int J Oncol; 2001 Dec; 19(6):1155-60. PubMed ID: 11713584
[TBL] [Abstract][Full Text] [Related]
3. Infiltrating breast carcinoma smaller than 0.5 centimeters: is lymph node dissection necessary?
Saiz E; Toonkel R; Poppiti RJ; Robinson MJ
Cancer; 1999 May; 85(10):2206-11. PubMed ID: 10326699
[TBL] [Abstract][Full Text] [Related]
4. Therapeutic options and results for the management of minimally invasive carcinoma of the breast: influence of axillary dissection for treatment of T1a and T1b lesions.
White RE; Vezeridis MP; Konstadoulakis M; Cole BF; Wanebo HJ; Bland KI
J Am Coll Surg; 1996 Dec; 183(6):575-82. PubMed ID: 8957459
[TBL] [Abstract][Full Text] [Related]
5. Additional Nodal Disease Prediction in Breast Cancer with Sentinel Lymph Node Metastasis Based on Clinicopathological Features.
Orsaria P; Caredda E; Genova F; Materazzo M; Capuano I; Vanni G; Granai AV; DE Majo A; Portarena I; Sileri P; Petrella G; Palombi L; Buonomo OC
Anticancer Res; 2018 Apr; 38(4):2109-2117. PubMed ID: 29599329
[TBL] [Abstract][Full Text] [Related]
6. The Association of Extent of Axillary Surgery and Survival in Women with N2-3 Invasive Breast Cancer.
Park TS; Thomas SM; Rosenberger LH; Fayanju OM; Plichta JK; Blitzblau RC; Ong CT; Hyslop T; Hwang ES; Greenup RA
Ann Surg Oncol; 2018 Oct; 25(10):3019-3029. PubMed ID: 29978365
[TBL] [Abstract][Full Text] [Related]
7. Treatment results and prognostic factors of early breast cancer treated with a breast conserving operation and radiotherapy.
Kim KJ; Huh SJ; Yang JH; Park W; Nam SJ; Kim JH; Lee JH; Kang SS; Lee JE; Kang MK; Park YJ; Nam HR
Jpn J Clin Oncol; 2005 Mar; 35(3):126-33. PubMed ID: 15741302
[TBL] [Abstract][Full Text] [Related]
8. The prognostic value of sentinel lymph node micrometastases in patients with invasive breast carcinoma.
Cipolla C; Graceffa G; La Mendola R; Fricano S; Fricano M; Vieni S
Ann Ital Chir; 2015; 86():497-502. PubMed ID: 26898168
[TBL] [Abstract][Full Text] [Related]
9. [Clinical features and prognosis in breast cancer patients over 70 years of age].
Zhao WH; Xu BH; Li Q; Zhang P; Sun Y
Zhonghua Zhong Liu Za Zhi; 2006 May; 28(5):385-8. PubMed ID: 17045008
[TBL] [Abstract][Full Text] [Related]
10. The Optimal Treatment Plan to Avoid Axillary Lymph Node Dissection in Early-Stage Breast Cancer Patients Differs by Surgical Strategy and Tumor Subtype.
Pilewskie M; Zabor EC; Mamtani A; Barrio AV; Stempel M; Morrow M
Ann Surg Oncol; 2017 Nov; 24(12):3527-3533. PubMed ID: 28762114
[TBL] [Abstract][Full Text] [Related]
11. [Microinvasive ductal carcinoma of the breast. Role of axillary lymph node dissection].
Le Bouëdec G; Penault-Llorca F; de Latour M; Joubert J; Kauffmann P; Pomel C; Dauplat J
J Gynecol Obstet Biol Reprod (Paris); 1999 Feb; 28(1):10-6. PubMed ID: 10394511
[TBL] [Abstract][Full Text] [Related]
12. Detection of hepatocyte growth factor/scatter factor receptor (c-Met) and MUC1 from the axillary fluid drainage in patients after breast cancer surgery.
Greenberg R; Barnea Y; Schneebaum S; Kashtan H; Kaplan O; Skornik Y
Isr Med Assoc J; 2003 Sep; 5(9):649-52. PubMed ID: 14509156
[TBL] [Abstract][Full Text] [Related]
13. Characteristics and outcomes of sentinel node-positive breast cancer patients after total mastectomy without axillary-specific treatment.
Milgrom S; Cody H; Tan L; Morrow M; Pesce C; Setton J; Rogers K; Arnold B; Eaton A; Catalano J; McCormick B; Powell S; Ho A
Ann Surg Oncol; 2012 Nov; 19(12):3762-70. PubMed ID: 22576064
[TBL] [Abstract][Full Text] [Related]
14. Is axillary lymph node dissection necessary in elderly patients with breast carcinoma who have a clinically uninvolved axilla?
Martelli G; Miceli R; De Palo G; Coradini D; Salvadori B; Zucali R; Galante E; Marubini E
Cancer; 2003 Mar; 97(5):1156-63. PubMed ID: 12599220
[TBL] [Abstract][Full Text] [Related]
15. A Dutch Prediction Tool to Assess the Risk of Additional Axillary Non-Sentinel Lymph Node Involvement in Sentinel Node-Positive Breast Cancer Patients.
van den Hoven I; van Klaveren D; Voogd AC; Vergouwe Y; Tjan-Heijnen V; Roumen RM
Clin Breast Cancer; 2016 Apr; 16(2):123-30. PubMed ID: 26602438
[TBL] [Abstract][Full Text] [Related]
16. [Prognostic value of estrogen receptor, progesterone receptor and human epidermal growth factor receptor-2 in node positive breast cancer patients treated by mastectomy].
Wang SL; Li YX; Song YW; Wang WH; Jin J; Liu YP; Liu XF; Yu ZH
Zhonghua Zhong Liu Za Zhi; 2010 Jul; 32(7):520-5. PubMed ID: 21029696
[TBL] [Abstract][Full Text] [Related]
17. Prognostic significance of signal transducer and activator of transcription 1 activation in breast cancer.
Widschwendter A; Tonko-Geymayer S; Welte T; Daxenbichler G; Marth C; Doppler W
Clin Cancer Res; 2002 Oct; 8(10):3065-74. PubMed ID: 12374673
[TBL] [Abstract][Full Text] [Related]
18. Prognostic roles of signal transducers and activators of transcription family in human breast cancer.
Wang S; Yu L; Shi W; Li X; Yu L
Biosci Rep; 2018 Dec; 38(6):. PubMed ID: 29326301
[TBL] [Abstract][Full Text] [Related]
19. Predictors of axillary lymph node metastases in patients with T1 breast carcinoma.
Barth A; Craig PH; Silverstein MJ
Cancer; 1997 May; 79(10):1918-22. PubMed ID: 9149018
[TBL] [Abstract][Full Text] [Related]
20. Feasibility of breast-conserving therapy for younger women with breast cancer.
Guenther JM; Kirgan DM; Giuliano AE
Arch Surg; 1996 Jun; 131(6):632-6. PubMed ID: 8645070
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
